Fischer, Leo
Mann, Paula Antonia
Nguyen, Minh-Hieu H.
Becker, Stefan
Khodadadi, Shiva
Schulz, Antonia
Edwin Thanarajah, Sharmili
Repple, Jonathan
Hahn, Tim
Reif, Andreas
Salamikhanshan, Amir
Kittel-Schneider, Sarah
Rief, Winfried
Mulert, Christoph
Hofmann, Stefan G.
Dannlowski, Udo
Kircher, Tilo
Bernhard, Felix P.
Jamalabadi, Hamidreza
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (521379614, 521379614, 521379614)
University Hospital of Gießen and Marburg (1/2024 MR, 1/2024 MR)
Philipps-Universität Marburg
Article History
Received: 17 November 2024
Accepted: 9 May 2025
First Online: 6 June 2025
Declarations
:
: This study was reviewed and approved by the Ethics Committee of the Faculty of Medicine, University of Marburg (Approval Letter No.: Jamalabadi 260623). The approval process ensures high ethical standards, including compliance with the principles of the Declaration of Helsinki. The approval was contingent upon the irreversible anonymization of all interview data, which was implemented prior to analysis. Written informed consent was obtained from all participants prior to their inclusion in the study.
: AR has received honoraria for lectures and/or advisory boards from Janssen, Boehringer Ingelheim, Compass, GH Research, SAGE/Biogen, LivaNova, Medice, Shire/Takeda, Newron, MSD, AbbVie and cyclerion. Also, he has received research grants from Medice and Janssen. JR has received speaker’s honoraria from Janssen, Hexal, Neuraxpharm and Novartis. SET served on an advisory board of Johnson and Johnson. SGH receives compensation for his work as editor from Springer Nature and royalties and payments for his work from various publishers.